翔宇药业 (832276.OC)

+ 收藏

利润表(单季度)(翔宇药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2019年第三季度2019年第二季度2019年第一季度2018年第四季度2018年第三季度2018年第二季度2018年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 87,073,948.55121,546,235.2991,410,777.4679,170,558.2296,343,383.54118,955,551.9580,054,238.31
 营业收入(元) 87,073,948.55121,546,235.2991,410,777.4679,170,558.2296,343,383.54118,955,551.9580,054,238.31
二、营业总成本(元) 81,132,115.05116,309,257.0284,134,176.56123,339,412.8687,327,964.8097,921,024.2071,073,895.76
 营业成本(元) 46,716,857.9176,764,331.3754,548,931.9464,949,595.1654,599,804.6853,785,747.3738,447,711.52
 研发费用(元) 5,991,547.685,473,518.874,901,138.0019,473,178.873,441,312.10--
 营业税金及附加(元) 1,389,948.961,556,059.401,686,336.182,191,056.262,111,942.882,931,206.851,867,436.45
 销售费用(元) 15,130,928.2417,794,680.6214,842,775.9016,193,825.5216,203,611.1819,048,679.5917,494,417.46
 管理费用(元) 8,103,062.0011,777,454.944,670,540.9610,334,510.928,430,402.664,589,102.3810,784,706.18
 财务费用(元) 3,682,994.143,935,692.633,484,453.583,381,583.334,087,603.305,254,212.852,594,765.66
  其中:利息费用(元) -----
  其中:利息收入(元) -----
 资产减值损失(元) ---6,815,662.80-1,546,712.002,593,228.69-115,141.51
 信用减值损失(元) -----
三、其他经营收益
 净敞口套期收益(元) -----
 资产处置收益(元) -----
 其他收益(元) -----
四、营业利润(元) 5,941,833.505,294,632.897,276,600.90-21,742,075.339,015,418.7421,100,790.688,914,079.62
 加:营业外收入(元) 180,732.2735,311.486,610.01-796,890.4884,930.6150,011.89710,676.76
 减:营业外支出(元) 299,236.821,941.184,925.29-335,131.4052,565.1298,699.69400,924.97
五、利润总额(元) 5,823,328.955,328,003.197,278,285.62-22,203,834.419,047,784.2321,052,102.889,223,831.41
 减:所得税费用(元) 809,723.17929,527.861,097,191.63-3,202,943.591,752,936.712,587,129.171,379,350.26
六、净利润(元) 5,013,605.784,398,475.336,181,093.99-19,000,890.827,294,847.5218,464,973.717,844,481.15
(一)按经营持续性分类
  持续经营净利润(元) -----
  终止经营净利润(元) -----
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 5,027,327.464,415,484.866,199,256.63-19,179,871.557,310,689.0918,464,970.897,869,165.18
  少数股东损益(元) -13,721.68-17,009.53-18,162.64178,980.73-15,841.572.82-24,684.03
 扣除非经常性损益后的净利润(元) 5,128,056.334,338,113.676,197,824.62-37,743,605.377,283,178.4318,450,032.037,662,199.65
七、每股收益
 一、基本每股收益(元) 0.030.030.03-0.100.040.100.04
 二、稀释每股收益(元) 0.030.030.03-0.04-0.05
八、其他综合收益(元) ----7,294,847.52--
 归属于母公司股东的其他综合收益(元) ----7,310,689.09--
 归属于少数股东的其他综合收益(元) -----15,841.57--
九、综合收益总额(元) 5,013,605.784,398,475.336,181,093.99-19,000,890.827,294,847.5218,464,973.717,844,481.15
 归属于母公司所有者的综合收益总额(元) 5,027,327.464,415,484.866,199,256.63-19,179,871.557,310,689.0918,464,970.897,869,165.18
 归属于少数股东的综合收益总额(元) -13,721.68-17,009.53-18,162.64178,980.73-15,841.572.82-24,684.03
公告日期 2019-10-312019-08-232019-04-292019-04-292018-10-312018-08-302018-04-27
审计意见(境内) 标准无保留意见

前瞻产业研究院